Skip to content

BlackRock Bets on Ripple XRP Technology – Implications for the Global Healthcare Market

In a development shaking up the financial world, Ripple and the tokenization platform Securitize have announced a partnership that allows holders of BlackRock and VanEck's tokenized treasury funds to exchange their shares for the stablecoin RLUSD around the clock. This integration, officially confirmed on September 23, 2025, affects BlackRock's BUIDL fund and VanEck's VBILL fund, which together manage over two billion US dollars in volume. This is one of the first practical uses of a stablecoin in institutional products, combining traditional bonds with the speed and flexibility of the blockchain. The announcement underscores Ripple's growing influence in the digital assets space and could revitalize the XRP market by promoting the use of the underlying XRP Ledger.

The BUIDL fund, BlackRock's USD Institutional Digital Liquidity Fund, tokenizes short-term US Treasury bonds and has rapidly gained scale since its launch in March 2024, with around 90 qualified investors. VBILL, VanEck's Treasury Fund, launched in May 2025, complements this with a similar approach and currently manages approximately 74 million US dollars on platforms like Ethereum, BNB Chain, Solana, and Avalanche. Through the new smart contract on the Securitize platform, investors can now convert their fund shares into RLUSD at any time, enabling real-time transactions without the usual delays of traditional settlements. RLUSD, Ripple's dollar-pegged stablecoin introduced in early 2025, is specifically designed for institutional requirements and is serviced by reputable custodians such as Bank of New York Mellon. The integration initially launched for BUIDL and will be rolled out to VBILL in the coming days, with plans to incorporate the XRP Ledger to further enhance interoperability.

This collaboration marks a milestone in the tokenization of real-world assets, as it not only creates liquidity but also opens up access to DeFi strategies and on-chain yields for institutional investors. Securitize, which already manages over four billion US dollars in tokenized assets and cooperates with managers such as Apollo, KKR, and Hamilton Lane, is thus positioning itself as a central interface between Wall Street and crypto infrastructure. The initiative fits into Ripple's broader strategy of linking traditional financial products with blockchain, as recently seen in partnerships with DBS and Franklin Templeton for tokenized loans and trading. On platforms like X, the development is being hotly debated, with posts celebrating the transition from days to seconds in settlement as a game-changer and highlighting the growing institutional demand for such solutions.

Impact on the Global Healthcare Market

The integration of RLUSD into tokenized treasury funds could transform the global healthcare market on multiple levels by enabling more efficient capital flows and innovative financing models. The sector, which generates over eight trillion US dollars annually worldwide and depends heavily on investments in research, infrastructure, and technology, benefits from growing tokenization, which brings liquidity and cost savings. First and foremost, this development creates a seamless bridge to high-risk, high-return assets: Institutional investors, including pension funds and insurance companies that traditionally invest in stable treasuries, can now convert funds like BUIDL and VBILL into RLUSD with minimal effort and redirect these funds to healthcare-specific projects. Such funds could in the future include tokenized healthcare assets, such as pharmaceutical patents or clinic real estate, thereby facilitating access to capital for biotech startups and global health initiatives.

A key effect lies in improving liquidity for healthcare financing. The market currently suffers from slow settlements and high transaction costs, especially for cross-border payments for drugs, equipment, or clinical trials. Through RLUSD-backed tokenization, redemptions and transfers could occur 24/7, accelerating the financing of pandemic resilience programs or AI-powered diagnostics. For example, hospitals or pharmaceutical companies could issue tokenized bonds traded on the XRP Ledger, thereby achieving more favorable terms – savings that are crucial in a sector with tight margins. This also promotes inclusion: In emerging markets, where the healthcare market is projected to grow to over two trillion US dollars by 2030, RLUSD could enable micro-investments in local clinics or vaccination programs by providing regulatory-compliant, stable currency on a blockchain basis.

In the long term, the partnership could lower regulatory hurdles and drive innovation. The healthcare sector is highly regulated, but the institutional acceptance of stablecoins like RLUSD – supported by BlackRock and VanEck – signals to authorities like the SEC or EMA that tokenized assets are secure and scalable. This could lead to new frameworks that allow for tokenized health data or supply chain tracking, reducing fraud and increasing efficiency. However, it carries risks: increased reliance on blockchain could heighten cyber threats, and the focus on US Treasuries could amplify currency fluctuations in non-dollarized markets. Overall, however, the benefits outweigh the risks: the initiative could make the healthcare market up to 10-15 percent more efficient, saving billions in transaction costs annually and channeling fresh capital into growth areas like telemedicine and personalized medicine. This development underscores how financial innovations can make the global healthcare sector more resilient and accessible.

author avatar
LabNews Media LLC
The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They are bestselling authors, science writers and science journalists since 1994.More details about their writing on X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
LabNews Media LLC

LabNews Media LLC

The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They have been bestselling authors, science writers, and science journalists since 1994.More details about their writing at X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu